ICU MEDICAL INC/DE (ICUI) Free cash flow
- Free cash flow · 12 months (USD): Value $152.83M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value 7.08%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $152.83M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $236.37M − $83.54M ≈ $152.83M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 7.08% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $152.83M ÷ $2.16B × 100 ≈ 7.08% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $236.37M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | (m) | Operating cash flow / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 236.37M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 83.54M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 152.83M USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 2.16B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | (m) | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $152.83M | (m) | $236.37M | $83.54M | (m) | $2.16B | (m) | (m) | (m) | (m) | 7.08% | (m) |
| 2026-03-31 | $82.70M | (m) | $167.43M | $84.72M | (m) | $2.16B | (m) | $46.34M | (m) | (m) | 3.83% | 3.61× |
| 2025-12-31 | $91.80M | (m) | $179.85M | $88.04M | (m) | $2.23B | (m) | $732.00K | (m) | (m) | 4.11% | 245.69× |
| 2025-09-30 | $71.96M | (m) | $159.44M | $87.48M | (m) | $2.32B | (m) | (m) | (m) | (m) | 3.10% | (m) |
| 2025-06-30 | $60.52M | (m) | $138.83M | $78.31M | (m) | $2.37B | (m) | (m) | (m) | (m) | 2.55% | (m) |
| 2025-03-31 | $131.49M | (m) | $209.57M | $78.08M | (m) | $2.42B | (m) | $-93.69M | (m) | (m) | 5.43% | -2.24× |
| 2024-12-31 | $124.66M | (m) | $204.03M | $79.37M | (m) | $2.38B | (m) | $-117.69M | (m) | (m) | 5.23% | -1.73× |
| 2024-09-30 | $169.88M | (m) | $255.11M | $85.23M | (m) | $2.34B | (m) | (m) | (m) | (m) | 7.26% | (m) |
| 2024-06-30 | $167.39M | (m) | $254.17M | $86.79M | (m) | $2.30B | (m) | (m) | (m) | (m) | 7.26% | (m) |
| 2024-03-31 | $85.14M | (m) | $170.75M | $85.60M | (m) | $2.26B | (m) | (m) | (m) | (m) | 3.77% | (m) |
| 2023-12-31 | $82.31M | (m) | $166.20M | $83.89M | (m) | $2.26B | (m) | $-29.66M | (m) | (m) | 3.64% | -5.60× |
| 2023-09-30 | $-2.33M | (m) | $73.22M | $75.55M | (m) | $2.25B | (m) | (m) | (m) | (m) | -0.10% | (m) |
| 2023-06-30 | $-34.39M | (m) | $40.37M | $74.76M | (m) | $2.29B | (m) | (m) | (m) | (m) | -1.50% | (m) |
| 2023-03-31 | $-100.45M | (m) | $-19.54M | $80.91M | (m) | $2.31B | (m) | $-46.03M | (m) | (m) | -4.36% | 0.42× |
| 2022-12-31 | $-152.44M | (m) | $-62.13M | $90.31M | (m) | $2.28B | (m) | $-74.29M | (m) | (m) | -6.69% | 0.84× |
| 2022-09-30 | $-68.59M | (m) | $22.20M | $90.79M | (m) | $2.04B | (m) | (m) | (m) | (m) | -3.36% | (m) |
| 2022-06-30 | $11.84M | (m) | $98.73M | $86.89M | (m) | $1.78B | (m) | (m) | (m) | (m) | 0.66% | (m) |
| 2022-03-31 | $136.76M | (m) | $214.88M | $78.12M | (m) | $1.54B | (m) | $41.34M | (m) | (m) | 8.87% | 5.20× |
| 2021-12-31 | $199.00M | (m) | $267.54M | $68.54M | (m) | $1.32B | (m) | $103.14M | (m) | (m) | 15.12% | 2.59× |
| 2021-09-30 | $187.34M | (m) | $263.44M | $76.11M | (m) | $1.30B | (m) | $109.35M | (m) | (m) | 14.45% | 2.41× |
| 2021-06-30 | $176.91M | (m) | $260.09M | $83.18M | (m) | $1.28B | (m) | $103.26M | (m) | (m) | 13.83% | 2.52× |
| 2021-03-31 | $153.98M | (m) | $234.55M | $80.57M | (m) | $1.26B | (m) | $93.77M | (m) | (m) | 12.22% | 2.50× |
| 2020-12-31 | $130.75M | (m) | $222.75M | $92.00M | (m) | $1.27B | (m) | $86.87M | (m) | (m) | 10.29% | 2.56× |
| 2020-09-30 | $106.67M | (m) | $193.09M | $86.42M | (m) | $1.27B | (m) | $81.37M | (m) | (m) | 8.43% | 2.37× |
| 2020-06-30 | $81.30M | (m) | $168.40M | $87.10M | (m) | $1.25B | (m) | $82.95M | (m) | (m) | 6.48% | 2.03× |
| 2020-03-31 | $68.34M | (m) | $162.45M | $94.10M | (m) | $1.26B | (m) | $86.87M | (m) | (m) | 5.41% | 1.87× |
| 2019-12-31 | $4.61M | (m) | $101.92M | $97.31M | (m) | $1.27B | (m) | $101.03M | (m) | (m) | 0.36% | 1.01× |
| 2019-09-30 | $12.07M | (m) | $102.99M | $90.92M | (m) | $1.29B | (m) | $73.04M | (m) | (m) | 0.93% | 1.41× |
| 2019-06-30 | $9.44M | (m) | $103.52M | $94.08M | (m) | $1.31B | (m) | $46.70M | (m) | (m) | 0.72% | 2.22× |
| 2019-03-31 | $65.09M | (m) | $159.94M | $94.85M | (m) | $1.36B | (m) | $54.92M | (m) | (m) | 4.79% | 2.91× |
| 2018-12-31 | $67.50M | (m) | $160.22M | $92.72M | (m) | $1.40B | (m) | $28.79M | (m) | (m) | 4.82% | 5.56× |
| 2018-09-30 | $97.00M | (m) | $194.83M | $97.83M | (m) | $1.43B | (m) | (m) | (m) | (m) | 6.78% | (m) |
| 2018-06-30 | $147.60M | (m) | $242.24M | $94.64M | (m) | $1.45B | (m) | (m) | (m) | (m) | 10.21% | (m) |
| 2018-03-31 | $125.67M | (m) | $210.30M | $84.63M | (m) | $1.42B | (m) | (m) | (m) | (m) | 8.87% | (m) |
| 2017-12-31 | $79.94M | (m) | $154.42M | $74.48M | (m) | $1.29B | (m) | $68.64M | (m) | (m) | 6.18% | 2.25× |
| 2017-09-30 | $31.06M | (m) | $91.11M | $60.05M | (m) | $1.02B | (m) | (m) | (m) | (m) | 3.05% | (m) |
| 2017-06-30 | $-22.15M | (m) | $19.30M | $41.45M | (m) | $772.05M | (m) | (m) | (m) | (m) | -2.87% | (m) |
| 2017-03-31 | $-39.76M | (m) | $-3.96M | $35.79M | (m) | $537.26M | (m) | (m) | (m) | (m) | -7.40% | (m) |
| 2016-12-31 | $66.58M | (m) | $89.94M | $23.36M | (m) | $379.37M | (m) | $63.08M | (m) | (m) | 17.55% | 1.43× |
| 2016-09-30 | $54.67M | (m) | $74.94M | $20.27M | (m) | $374.07M | (m) | (m) | (m) | (m) | 14.61% | (m) |
| 2016-06-30 | $50.37M | (m) | $67.47M | $17.09M | (m) | $362.98M | (m) | (m) | (m) | (m) | 13.88% | (m) |
| 2016-03-31 | $41.81M | (m) | $56.40M | $14.59M | (m) | $350.04M | (m) | (m) | (m) | (m) | 11.94% | (m) |
| 2015-12-31 | $41.88M | (m) | $54.87M | $12.98M | (m) | $341.67M | (m) | $44.98M | (m) | (m) | 12.26% | 1.22× |
| 2015-09-30 | $45.32M | (m) | $54.73M | $9.41M | (m) | $331.18M | (m) | (m) | (m) | (m) | 13.68% | (m) |
| 2015-06-30 | $48.23M | (m) | $57.12M | $8.88M | (m) | $322.62M | (m) | (m) | (m) | (m) | 14.95% | (m) |
| 2015-03-31 | $48.12M | (m) | $61.18M | $13.05M | (m) | $317.51M | (m) | (m) | (m) | (m) | 15.16% | (m) |
| 2014-12-31 | $44.04M | (m) | $60.64M | $16.60M | (m) | $309.26M | (m) | $26.34M | (m) | (m) | 14.24% | 2.30× |
| 2014-09-30 | $53.71M | (m) | $71.83M | $18.12M | (m) | $307.31M | (m) | (m) | (m) | (m) | 17.48% | (m) |
| 2014-06-30 | $49.68M | (m) | $69.05M | $19.36M | (m) | $312.66M | (m) | (m) | (m) | (m) | 15.89% | (m) |
| 2014-03-31 | $49.18M | (m) | $67.68M | $18.49M | (m) | $312.65M | (m) | (m) | (m) | (m) | 15.73% | (m) |
| 2013-12-31 | $47.31M | (m) | $65.73M | $18.41M | (m) | $313.72M | (m) | $40.42M | (m) | (m) | 15.08% | 1.63× |
| 2013-09-30 | $46.41M | (m) | $67.58M | $21.18M | (m) | $318.45M | (m) | (m) | (m) | (m) | 14.57% | (m) |
| 2013-06-30 | $38.04M | (m) | $60.76M | $22.72M | (m) | $317.04M | (m) | (m) | (m) | (m) | 12.00% | (m) |
| 2013-03-31 | $37.34M | (m) | $58.70M | $21.36M | (m) | $315.66M | (m) | (m) | (m) | (m) | 11.83% | (m) |
| 2012-12-31 | $47.11M | (m) | $66.27M | $19.16M | (m) | $316.87M | (m) | $41.28M | (m) | (m) | 14.87% | 1.61× |
| 2012-09-30 | $54.10M | (m) | $69.37M | $15.27M | (m) | $310.67M | (m) | (m) | (m) | (m) | 17.41% | (m) |
| 2012-06-30 | $56.20M | (m) | $70.50M | $14.29M | (m) | $305.72M | (m) | (m) | (m) | (m) | 18.38% | (m) |
| 2012-03-31 | $53.14M | (m) | $67.66M | $14.51M | (m) | $306.24M | (m) | (m) | (m) | (m) | 17.35% | (m) |
| 2011-12-31 | $48.66M | (m) | $64.49M | $15.82M | (m) | $302.19M | (m) | (m) | (m) | (m) | 16.10% | (m) |
| 2011-09-30 | $31.14M | (m) | $50.33M | $19.18M | (m) | $301.35M | (m) | (m) | (m) | (m) | 10.34% | (m) |
| 2011-06-30 | $19.38M | (m) | $41.02M | $21.64M | (m) | $300.62M | (m) | (m) | (m) | (m) | 6.45% | (m) |
| 2011-03-31 | $20.32M | (m) | $38.06M | $17.74M | (m) | $291.69M | (m) | (m) | (m) | (m) | 6.97% | (m) |
| 2010-12-31 | $9.92M | (m) | $33.09M | $23.17M | (m) | $284.58M | (m) | (m) | (m) | (m) | 3.49% | (m) |
| 2010-09-30 | $2.93M | (m) | $27.20M | $24.28M | (m) | $278.78M | (m) | (m) | (m) | (m) | 1.05% | (m) |
| 2010-06-30 | $17.23M | (m) | $38.35M | $21.12M | (m) | $257.00M | (m) | (m) | (m) | (m) | 6.70% | (m) |
| 2010-03-31 | $13.53M | (m) | $38.45M | $24.92M | (m) | $241.54M | (m) | (m) | (m) | (m) | 5.60% | (m) |
| 2009-12-31 | $31.92M | (m) | $48.61M | $16.69M | (m) | $231.51M | (m) | (m) | (m) | (m) | 13.79% | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $18.88M | (m) | $30.23M | $11.35M | (m) | $204.73M | (m) | (m) | (m) | (m) | 9.22% | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $17.87M | (m) | $41.51M | $23.64M | (m) | $188.14M | (m) | (m) | (m) | (m) | 9.50% | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |